|
1
|
Yoshimoto S, Loo TM, Atarashi K, Kanda H,
Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, et
al: Obesity-induced gut microbial metabolite promotes liver cancer
through senescence secretome. Nature. 499:97–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mittal S and El-Serag HB: Epidemiology of
hepatocellular carcinoma: consider the population. J Clin
Gastroenterol. 47:S2–6. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang YC, Xu Z, Zhang TF and Wang YL:
Circulating microRNAs as diagnostic and prognostic tools for
hepatocellular carcinoma. World J Gastroenterol. 21:9853–9862.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kokudo N, Hasegawa K, Akahane M, Igaki H,
Izumi N, Ichida T, Uemoto S, Kaneko S, Kawasaki S, Ku Y, et al:
Evidence-based clinical practice guidelines for hepatocellular
carcinoma: The Japan society of hepatology 2013 update (3rd JSH-HCC
guidelines). Hepatol Res. 45:452015. View Article : Google Scholar
|
|
7
|
Chen Y, Zhang J, Wang H, Zhao J, Xu C, Du
Y, Luo X, Zheng F, Liu R, Zhang H, et al: miRNA-135a promotes
breast cancer cell migration and invasion by targeting HOXA10. BMC
Cancer. 12:1112012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hsu SD, Tseng YT, Shrestha S, Lin YL,
Khaleel A, Chou CH, Chu CF, Huang HY, Lin CM, Ho SY, et al:
miRTarBase update 2014: An information resource for experimentally
validated miRNA-target interactions. Nucleic Acids Res. 42(D1):
D78–D85. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee YJ, Kim V, Muth DC and Witwer KW:
Validated microRNA target databases:an evaluation. Drug Dev Res.
76:389–396. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kudo M, Matsui O, Izumi N, Iijima H,
Kadoya M, Imai Y, Okusaka T, Miyayama S, Tsuchiya K, Ueshima K, et
al: Liver Cancer Study Group of Japan: JSH consensus-based clinical
practice guidelines for the management of hepatocellular carcinoma:
2014 update by the Liver Cancer Study Group of Japan. Liver Cancer.
3:458–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reddy KB: MicroRNA (miRNA) in cancer.
Cancer Cell Int. 15:382015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shenoy A and Blelloch RH: Regulation of
microRNA function in somatic stem cell proliferation and
differentiation. Nat Rev Mol Cell Biol. 15:565–576. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang H, Li RP, Liang P, Zhou YL and Wang
GW: miR-125a inhibits the migration and invasion of liver cancer
cells via suppression of the PI3K/AKT/mTOR signaling pathway. Oncol
Lett. 10:681–686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu L, Chen X, Zhang Y, Hu Y, Shen X and
Zhu W: Long non-coding RNA TUG1 promotes endometrial cancer
development via inhibiting miR-299 and miR-34a-5p. Oncotarget.
8:31386–31394. 2017.PubMed/NCBI
|
|
15
|
Fateh A, Feizi MAH, Safaralizadeh R and
Azarbarzin S: Importance of miR-299-5p in colorectal cancer. Ann
Gastroenterol. 30:322–326. 2017.PubMed/NCBI
|
|
16
|
Xing Y, Cui D, Wang S, Wang P, Xing X and
Li H: Oleuropein represses the radiation resistance of ovarian
cancer by inhibiting hypoxia and microRNA-299-targetted heparanase
expression. Food Funct. 8:2857–2864. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Göhring AR, Reuter S, Clement JH, Cheng X,
Theobald J, Wölfl S and Mrowka R: Human microRNA-299-3p decreases
invasive behavior of cancer cells by downregulation of Oct4
expression and causes apoptosis. PLoS One. 12:e01749122017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim HS, Lee KS, Bae HJ, Eun JW, Shen Q,
Park SJ, Shin WC, Yang HD, Park M, Park WS, et al: MicroRNA-31
functions as a tumor suppressor by regulating cell cycle and
epithelial-mesenchymal transition regulatory proteins in liver
cancer. Oncotarget. 6:8089–8102. 2015.PubMed/NCBI
|
|
19
|
Li WF, Dai H, Ou Q, Zuo GQ and Liu CA:
Overexpression of microRNA-30a-5p inhibits liver cancer cell
proliferation and induces apoptosis by targeting MTDH/PTEN/AKT
pathway. Tumour Biol. 37:5885–5895. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuan Q, Loya K, Rani B, Möbus S,
Balakrishnan A, Lamle J, Cathomen T, Vogel A, Manns MP, Ott M, et
al: MicroRNA-221 overexpression accelerates hepatocyte
proliferation during liver regeneration. Hepatology. 57:299–310.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ren S, Xin Z, Xu Y, Xu J and Wang G:
Construction and analysis of circular RNA molecular regulatory
networks in liver cancer. Cell Cycle. 6:2204–2211. 2017. View Article : Google Scholar
|
